Literature DB >> 9619735

A case of bone marrow mastocytosis associated with multiple myeloma.

W Hagen1, J Schwarzmeier, S Walchshofer, N Zojer, A Chott, C Sillaber, J Ackermann, I Simonitsch, H J Bühring, J Drach, K Lechner, H P Horny, P Valent.   

Abstract

Mastocytosis is a term used for a spectrum of disorders characterized by abnormal growth and accumulation of mast cells. The cutaneous variants of the disease have to be distinguished from systemic mastocytosis (SM), in which at least one extracutaneous organ is involved. In contrast to cutaneous mastocytosis, SM is often associated with another hematologic neoplasm. In most cases clonal myeloid malignancies such as a myeloproliferative or myelodysplastic syndrome occur. In a few cases of SM, however, clonal lymphoid disorders have been described. We here report on a case of SM associated with multiple myeloma. At first presentation, the 48-year old female patient showed monoclonal IgGlambda gammopathy and bone marrow (BM) mastocytosis, but no BM plasma cell infiltrates. Eight years later, the patient presented with BM mastocytosis and overt multiple myeloma. The co-existence of myeloma and mastocytosis was demonstrable by staining serial BM sections with antibodies against mast cell tryptase, CD68R, and the plasma cell marker VS38c. Interphase FISH analysis of BM sections revealed a numeric gain of chromosome 5 and chromosome 7 in the plasma cells but not in the mast cell infiltrates, thereby confirming the presence of two different neoplastic cell populations. To our knowledge, this is the first report describing the co-existence of multiple myeloma and mastocytosis.

Entities:  

Mesh:

Year:  1998        PMID: 9619735     DOI: 10.1007/s002770050382

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

1.  Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm.

Authors:  T Gülen; B Sander; G Nilsson; J Palmblad; K Sotlar; H-P Horny; H Hägglund
Journal:  Med Oncol       Date:  2012-06-03       Impact factor: 3.064

2.  "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.

Authors:  K Sotlar; W Saeger; F Stellmacher; J Stahmer; S Jäckle; P Valent; H-P Horny
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

3.  Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.

Authors:  Shouying Du; Hooman H Rashidi; Dzung T Le; Thomas J Kipps; H Elizabeth Broome; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2010-04-23

4.  An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).

Authors:  H-P Horny; K Sotlar; F Stellmacher; P Valent; J Grabbe
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

5.  Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.

Authors:  H-P Horny; K Sotlar; W R Sperr; P Valent
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

6.  Systemic Mastocytosis Associated with "Smoldering" Multiple Myeloma.

Authors:  Magda Zanelli; Stefano Ricci; Maurizio Zizzo; Francesca Sanguedolce; Federica De Giorgi; Andrea Palicelli; Giovanni Martino; Stefano Ascani
Journal:  Diagnostics (Basel)       Date:  2021-01-07

7.  Clinical Outcomes of Adults with Systemic Mastocytosis: A 15-Year Multidisciplinary Experience.

Authors:  Johanna Ungerstedt; Christopher Ljung; Monika Klimkowska; Theo Gülen
Journal:  Cancers (Basel)       Date:  2022-08-16       Impact factor: 6.575

8.  Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case.

Authors:  Sassine Ghanem; Gwenalyn Garcia; Liu Ying; Matthew Hurford; Marcel Odaimi
Journal:  Case Rep Oncol Med       Date:  2016-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.